Objective To compare the effects of ultrasound cycloplasty(UCP)and 810 nm laser photocoagulation for the treatment of refractory glaucoma.Methods In this prospective study,40 patients(40 eyes)with refractory glau-coma admitted to the hospital between June 2022 and March 2024 were selected and divided by the random number table method into a UCP group(20 cases)and an 810 laser group(20 cases).The UCP group received UCP treatment and the 810 laser group underwent transscleral 810 nm laser cyclophotocoagulation.The general data of the patients and their in-traocular pressures before surgery,1 day,2 weeks and 3 months after surgery were compared.Moreover,the ocular hemo-dynamics[including resistance index(RI)and peak systolic velocity(PSV)of the posterior short ciliary artery,central ret-inal artery and ocular artery],numerical rating scale(NRS)scores and visual acuity 3 months after surgery were compared with those before surgery.The occurrence of complications within 3 months after surgery was compared between the two groups.Results The intraocular pressure was decreased in both groups and the intraocular pressure in the UCP group was lower than that in the 810 laser group 1 day,2 weeks and 3 months after surgery(all P＜0.05).Compared with the 810 laser group,the UCP group had lower RI,PSV and NRS scores but higher visual acuity 3 months after surgery(all P＜0.05).There was no significant difference in incidence of complications between UCP and 810 laser groups at the end of the follow-up(10.00％vs.15.00％,P＞0.05).Conclusion Compared with transscleral 810 nm laser cyclophotocoagu-lation,UCP can more effectively lower the intraocular pressure,promote the recovery of visual acuity and relieve pain in patients with refractory glaucoma while having comparable safety.

Objective To compare the effects of ultrasound cycloplasty(UCP)and 810 nm laser photocoagulation for the treatment of refractory glaucoma.Methods In this prospective study,40 patients(40 eyes)with refractory glau-coma admitted to the hospital between June 2022 and March 2024 were selected and divided by the random number table method into a UCP group(20 cases)and an 810 laser group(20 cases).The UCP group received UCP treatment and the 810 laser group underwent transscleral 810 nm laser cyclophotocoagulation.The general data of the patients and their in-traocular pressures before surgery,1 day,2 weeks and 3 months after surgery were compared.Moreover,the ocular hemo-dynamics[including resistance index(RI)and peak systolic velocity(PSV)of the posterior short ciliary artery,central ret-inal artery and ocular artery],numerical rating scale(NRS)scores and visual acuity 3 months after surgery were compared with those before surgery.The occurrence of complications within 3 months after surgery was compared between the two groups.Results The intraocular pressure was decreased in both groups and the intraocular pressure in the UCP group was lower than that in the 810 laser group 1 day,2 weeks and 3 months after surgery(all P＜0.05).Compared with the 810 laser group,the UCP group had lower RI,PSV and NRS scores but higher visual acuity 3 months after surgery(all P＜0.05).There was no significant difference in incidence of complications between UCP and 810 laser groups at the end of the follow-up(10.00％vs.15.00％,P＞0.05).Conclusion Compared with transscleral 810 nm laser cyclophotocoagu-lation,UCP can more effectively lower the intraocular pressure,promote the recovery of visual acuity and relieve pain in patients with refractory glaucoma while having comparable safety.

Sodium butyrate is a sodium salt of four-carbon short chain fatty acids produced by dietary fiber under the action of intestinal microorganisms,it can provide energy for intestinal epithelial cells,and plays an important role in maintaining the integrity of intestinal epithelial cells,inhibiting intestinal inflamma-tion and tumor.In recent years,many studies have indicated that sodium butyrate can mediate apoptosis of colorectal cancer cells by inhibiting histone deacetylase activity,cysteine protease mediation and endoplastic re-ticulum (ER) stress,suggesting that sodium butyrate may be a potential anti-colorectal cancer drug.This arti-cle aims to review the advance progress in the role and mechanism of sodium butyrate in colorectal cancer cell apoptosis,and briefly describe the relationship between sodium butyrate in maintaining intestinal microenvi-ronment and enhancing the immune barrier function of intestinal mucosa with inhibiting intestinal inflamma-tion in order to provide reference for the development of sodium butyrate as first-line anti-colorectal cancer drugs.

Objective To summary the pathological and clinical characteristics,treatments and prognosis of malignant renal perivascular epithelioid cell tumor (PEComa).Methods Between August 2013 and June 2017,8 cases of malignant renal PEComa were analysed respectively.Of all the patients,there were 4 males and 4 females,aged 27-65 years with the average of 46.3 years old.Three cases were detected in routine examination occasionally,three cases complained of intermittent back pain with fever,one presented with swollen and painful right hand and right foot,and one case presented with hematuria.CT or MRI examinations indicated the malignant lesions before the surgery.Clinical staging was performed with 2 cases of T1N0M0,1 case of T1 N0M1,2 cases of T2N0M0,1 case of T3M0M0,and 2 cases of T4N0M1.Three cases underwent radical nephrectomy,1 case underwent radical nephrectomy plus renal artery embolization,2 cases underwent partial nephrectomy,and 2 cases underwent nephrectomy plus inferior vena cava tumor thrombectomy.One case was treated with ifosfamide plus epirubicin after operation due to multiple distant metastases and 1 case was treated with oxaliplatin before the sugery because of excessive tumor diameter.None of the rest received any adjuvant therapy.Results Postoperative histopathological examination showed multiple nodules in reddish gray and yellow color,with soft texture and partial incomplete capsule.Microscopically,there were large atypical cell components,some of which were spindle shaped,with disordered cell arrangement,some of which were associated with a large amount of necrotic tissue,and abundant light eosinophil cytoplasm.Tissue components can be found thick-wall blood vessels,smooth muscle-like cells,and adipose tissue.Immunohistochemistry showed 4 cases were positive of HMB-45,4 of Melan-A,7 of SAM.Seven cases were negative of CK,6 of S-100 75％ (6/8) and Ki67 (10％-70％).Two cases died of multiple metastases (lung,bone,liver),1 case survived with tumor recurrence,with a follow-up from 14 to 60 months (mean 29 months).Conclusions Primary malignant renal PEComa is rare in practice with relative large diameter.The diagnosis depends on pathological findings,and radical nephrectomy is the first choice of treatment.It is easy to recur and metastasize after the operation.

Objective To investigate the efficacy and safety of Nocardiarubra cell wall skeleton (N-CWS) bladder irrigation in prevention of recurrence after transurethral resection for the treatment of non-muscle invasive bladder cancer (NMIBC).Methods The clinical data of patients with NMIBC treated by N-CWS and epirubicin collected between October 2013 and November 2018 at the First Affiliated Hospital of Zhengzhou University were retrospectively analyzed.All patients underwent TURBT.Among the 118 NMIBC patients,the average age was (65.1 ± 1 1.9) years,and the sex ratio (male/female) was 1.9∶1 (77/41).Patients were divided into two group:N-CWS group (n =55) and epirubicin group (n =63) according to different instillation regimens.N-CWS was given as an instillation of 800 μg in 50 ml of saline and maintained in the bladder for 2 h in the N-CWS group.Epirubicin was given as an instillation of 50 mg in 50 ml of saline and maintained in the bladder for 1 h in the epirubicin group.In the N-CWS group,mean agewas (64.9 ± 12.1) years and 37 (67.3％) were male.Multiple tumors were present in 17 (69.1％) patients.Tumor size was ≤3 cm in 49(89.1％) and 7(12.7％) had a history of NMIBC.Stage was Ta and T1 in 36(65.5％) and 19(34.5％),respectively.Grade 1,Grade 2 and Grade 3 were the primary grades in 38(69.1％),13(23.6％) and 4(7.3％),respectively.Low risk,intermediate risk and high risk were present in 14 patients(25.5％),16 (29.1％) and 25 (45.5％),respectively.In the epirubicin group,mean age was (65.3 ± 11.2) years and 40(63.5％)were male.Multiple tumors were present in 19(30.2％) patients.Tumor size was ≤3 cm in 56(88.9％) and 11 (17.5％) had a history of NMIBC.Stage was Ta and T1 in 37(58.7％) and 26 (41.3％),respectively.Grade 1,Grade 2 and Grade 3 were the primary grades in 44(69.8％),12(19.0％)and 7(11.1％),respectively.Low risk,intermediate risk and high risk were present in 13 (20.6％),19 (30.2％) and 31 (49.2％),respectively.The tumor recurrence,progression and adverse reactions after Intravesical Instillation in both groups were followed up and recorded.No significant differences were found between the two groups.Results A total of 118 patients were followed up.Mean follow-up time was (33.7 ± 5.4) months.25.5％ (14/55) in the N-CWS group vs.42.8％ (27/63) in the epirubicin group had recurrence after 5 years (x2 =3.922,P =0.048).The five-year RFS was higher in the N-CWS group than in the epirubicin group (74.2％ vs.56.5％,P =0.044).No significant difference was found in the progression rate between the two groups(5.5％ vs.7.9％,P =0.867).The incidences of adverse events in the two groups were 16.4％ (9/55) and 19.0％ (12/63),respectively.The N-CWS group had significantly fewer cases with urinary frequency and dysuria than the epirubicin group.No significant differences were found in other side effects.Conclusions Intravesical instillation of N-CWS after NMIBC TURBT was found to be a promising procedure to prevent recurrence and prolong the recurrence-free survival with less side effects.

Objective To comprehensively evaluate the relationship between children's high iodine goiter and excessive iodine . Methods A computerized literature search was carried out to collect articles published before 2014 in electronic databases CBM , WabFang ,VIP ,CNKI ,PubMed ,EMbase ,Ovid and Cochrane Library .The study type was randomized controlled trial or quasi‐ran‐domized control trial .Literature was analyzed by RevMan5 .0 software ,then calculated and combine RR and 95% CI .Publication bi‐as of Meta analysis was evaluated by Begg's test ,Egger's test and Macaskill's test .The result stability of Meta analysis was tested by sensibility analysis .Results A total of 10 controlled before and after studies were included in our meta‐analysis .The result showed that the iodine content of 150 -300 μg/L (RR:1 .54 ;95% CI:1 .14 -2 .07);301 -600 μg/L (RR:2 .33;95% CI:1 .43 -3 .82);601-900 μg/L (RR:2 .72 :95% CI:1 .01-7 .33) and greater than 900μg/L (RR:2 .41 ;95% CI:1 .38-4 .23) would result in chil‐dren goiter .Conclusion Iodine content greater than 150 μg/L would result in children goiter .